TransCode Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

CEO

Thomas A. Fitzgerald

CEOThomas A. Fitzgerald

Employees

Employees10

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2016

Founded2016

Employees

Employees10

RNAZ Key Statistics

Market cap

5.00M

Market cap5.00M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

655.07K

Average volume655.07K

High today

$1.05

High today$1.05

Low today

$0.6902

Low today$0.6902

Open price

$0.75

Open price$0.75

Volume

5.49M

Volume5.49M

52 Week high

$309.60

52 Week high$309.60

52 Week low

$0.42

52 Week low$0.42

TransCode Therapeutics

Why Robinhood?

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA. Show more

RNAZ Key Statistics

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.